近5年高被引文献
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
article
Full Text
OpenAlex
1982
FWCI665.69359911
The hallmarks of cancer metabolism: Still emerging
review
Full Text
OpenAlex
1210
FWCI166.54673195
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
article
Full Text
OpenAlex
1111
FWCI958.74031292
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
review
Full Text
OpenAlex
886
FWCI178.40092953
New insights into activation and function of the AMPK
review
Full Text
OpenAlex
793
FWCI96.85542733
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
article
Full Text
OpenAlex
777
FWCI260.35717317
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
article
Full Text
OpenAlex
756
FWCI158.60200701
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
article
Full Text
OpenAlex
727
FWCI151.44069461
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
review
Full Text
OpenAlex
707
FWCI88.11751711
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
review
Full Text
OpenAlex
673
FWCI125.32752515